189 related articles for article (PubMed ID: 29847803)
1. Enhancer and Transcription Factor Dynamics during Myeloid Differentiation Reveal an Early Differentiation Block in Cebpa null Progenitors.
Pundhir S; Bratt Lauridsen FK; Schuster MB; Jakobsen JS; Ge Y; Schoof EM; Rapin N; Waage J; Hasemann MS; Porse BT
Cell Rep; 2018 May; 23(9):2744-2757. PubMed ID: 29847803
[TBL] [Abstract][Full Text] [Related]
2. In Vivo Deletion of the Cebpa +37 kb Enhancer Markedly Reduces Cebpa mRNA in Myeloid Progenitors but Not in Non-Hematopoietic Tissues to Impair Granulopoiesis.
Guo H; Cooper S; Friedman AD
PLoS One; 2016; 11(3):e0150809. PubMed ID: 26937964
[TBL] [Abstract][Full Text] [Related]
3. The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors.
Cooper S; Guo H; Friedman AD
PLoS One; 2015; 10(5):e0126385. PubMed ID: 25938608
[TBL] [Abstract][Full Text] [Related]
4. HoxA9 binds and represses the Cebpa +8 kb enhancer.
Peng L; Guo H; Ma P; Sun Y; Dennison L; Aplan PD; Hess JL; Friedman AD
PLoS One; 2019; 14(5):e0217604. PubMed ID: 31120998
[TBL] [Abstract][Full Text] [Related]
5. The Cebpa +37-kb enhancer directs transgene expression to myeloid progenitors and to long-term hematopoietic stem cells.
Guo H; Ma O; Friedman AD
J Leukoc Biol; 2014 Sep; 96(3):419-26. PubMed ID: 24868087
[TBL] [Abstract][Full Text] [Related]
6. The regulatory control of Cebpa enhancers and silencers in the myeloid and red-blood cell lineages.
Repele A; Krueger S; Bhattacharyya T; Tuineau MY; Manu
PLoS One; 2019; 14(6):e0217580. PubMed ID: 31181110
[TBL] [Abstract][Full Text] [Related]
7. Impaired myelopoiesis in mice devoid of interferon regulatory factor 1.
Testa U; Stellacci E; Pelosi E; Sestili P; Venditti M; Orsatti R; Fragale A; Petrucci E; Pasquini L; Belardelli F; Gabriele L; Battistini A
Leukemia; 2004 Nov; 18(11):1864-71. PubMed ID: 15385939
[TBL] [Abstract][Full Text] [Related]
8. PML-retinoic acid receptor alpha inhibits PML IV enhancement of PU.1-induced C/EBPepsilon expression in myeloid differentiation.
Yoshida H; Ichikawa H; Tagata Y; Katsumoto T; Ohnishi K; Akao Y; Naoe T; Pandolfi PP; Kitabayashi I
Mol Cell Biol; 2007 Aug; 27(16):5819-34. PubMed ID: 17562868
[TBL] [Abstract][Full Text] [Related]
9. PU.1 activation relieves GATA-1-mediated repression of Cebpa and Cbfb during leukemia differentiation.
Burda P; Curik N; Kokavec J; Basova P; Mikulenkova D; Skoultchi AI; Zavadil J; Stopka T
Mol Cancer Res; 2009 Oct; 7(10):1693-703. PubMed ID: 19825991
[TBL] [Abstract][Full Text] [Related]
10. Runx1 deletion or dominant inhibition reduces Cebpa transcription via conserved promoter and distal enhancer sites to favor monopoiesis over granulopoiesis.
Guo H; Ma O; Speck NA; Friedman AD
Blood; 2012 May; 119(19):4408-18. PubMed ID: 22451420
[TBL] [Abstract][Full Text] [Related]
11. Granulopoiesis requires increased C/EBPα compared to monopoiesis, correlated with elevated Cebpa in immature G-CSF receptor versus M-CSF receptor expressing cells.
Ma O; Hong S; Guo H; Ghiaur G; Friedman AD
PLoS One; 2014; 9(4):e95784. PubMed ID: 24752325
[TBL] [Abstract][Full Text] [Related]
12. An autonomous CEBPA enhancer specific for myeloid-lineage priming and neutrophilic differentiation.
Avellino R; Havermans M; Erpelinck C; Sanders MA; Hoogenboezem R; van de Werken HJ; Rombouts E; van Lom K; van Strien PM; Gebhard C; Rehli M; Pimanda J; Beck D; Erkeland S; Kuiken T; de Looper H; Gröschel S; Touw I; Bindels E; Delwel R
Blood; 2016 Jun; 127(24):2991-3003. PubMed ID: 26966090
[TBL] [Abstract][Full Text] [Related]
13. C/EBPalpha binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment.
Yeamans C; Wang D; Paz-Priel I; Torbett BE; Tenen DG; Friedman AD
Blood; 2007 Nov; 110(9):3136-42. PubMed ID: 17671233
[TBL] [Abstract][Full Text] [Related]
14. Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells.
Santilli G; Almarza E; Brendel C; Choi U; Beilin C; Blundell MP; Haria S; Parsley KL; Kinnon C; Malech HL; Bueren JA; Grez M; Thrasher AJ
Mol Ther; 2011 Jan; 19(1):122-32. PubMed ID: 20978475
[TBL] [Abstract][Full Text] [Related]
15. PU. 1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation.
Olson MC; Scott EW; Hack AA; Su GH; Tenen DG; Singh H; Simon MC
Immunity; 1995 Dec; 3(6):703-14. PubMed ID: 8777716
[TBL] [Abstract][Full Text] [Related]
16. Multiple PU.1 sites cooperate in the regulation of p40(phox) transcription during granulocytic differentiation of myeloid cells.
Li SL; Valente AJ; Qiang M; Schlegel W; Gamez M; Clark RA
Blood; 2002 Jun; 99(12):4578-87. PubMed ID: 12036891
[TBL] [Abstract][Full Text] [Related]
17. PU.1 and CEBPA expression in acute myeloid leukemia.
D'Alò F; Di Ruscio A; Guidi F; Fabiani E; Greco M; Rumi C; Hohaus S; Voso MT; Leone G
Leuk Res; 2008 Sep; 32(9):1448-53. PubMed ID: 18308386
[TBL] [Abstract][Full Text] [Related]
18. Pioneering, chromatin remodeling, and epigenetic constraint in early T-cell gene regulation by SPI1 (PU.1).
Ungerbäck J; Hosokawa H; Wang X; Strid T; Williams BA; Sigvardsson M; Rothenberg EV
Genome Res; 2018 Oct; 28(10):1508-1519. PubMed ID: 30171019
[TBL] [Abstract][Full Text] [Related]
19. Dynamic epigenetic enhancer signatures reveal key transcription factors associated with monocytic differentiation states.
Pham TH; Benner C; Lichtinger M; Schwarzfischer L; Hu Y; Andreesen R; Chen W; Rehli M
Blood; 2012 Jun; 119(24):e161-71. PubMed ID: 22550342
[TBL] [Abstract][Full Text] [Related]
20. Cooperative Activity of GABP with PU.1 or C/EBPε Regulates Lamin B Receptor Gene Expression, Implicating Their Roles in Granulocyte Nuclear Maturation.
Malu K; Garhwal R; Pelletier MG; Gotur D; Halene S; Zwerger M; Yang ZF; Rosmarin AG; Gaines P
J Immunol; 2016 Aug; 197(3):910-22. PubMed ID: 27342846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
